Plasminogen (medication): Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox drug | |||
| name = Plasminogen | |||
| image = <!-- Image of the drug --> | |||
| width = | |||
| alt = | |||
| caption = | |||
| pronounce = | |||
| tradename = | |||
| Drugs.com = | |||
| MedlinePlus = | |||
| pregnancy_AU = | |||
| pregnancy_US = | |||
| pregnancy_category = | |||
| legal_AU = | |||
| legal_CA = | |||
| legal_UK = | |||
| legal_US = | |||
| legal_status = | |||
| routes_of_administration = | |||
| bioavailability = | |||
| protein_bound = | |||
| metabolism = | |||
| elimination_half-life = | |||
| excretion = | |||
| CAS_number = | |||
| ATC_prefix = | |||
| ATC_suffix = | |||
| ATC_supplemental = | |||
| PubChem = | |||
| DrugBank = | |||
| ChemSpiderID = | |||
| UNII = | |||
| KEGG = | |||
| ChEBI = | |||
| ChEMBL = | |||
| synonyms = | |||
}} | |||
'''Plasminogen''' is a medication used in the treatment of certain medical conditions related to | '''Plasminogen''' is a [[medication]] used in the treatment of certain medical conditions related to [[fibrinolysis]]. It is a precursor to [[plasmin]], an important enzyme that breaks down [[fibrin]] clots. This medication is primarily used in the management of [[hypoplasminogenemia]], a rare condition characterized by low levels of plasminogen in the blood. | ||
== Mechanism of Action == | |||
Plasminogen is converted into its active form, [[plasmin]], by [[tissue plasminogen activator]] (tPA) or [[urokinase]]. Plasmin then degrades fibrin, a key component of blood clots, into soluble fragments. This process is crucial for the maintenance of normal blood flow and prevention of [[thrombosis]]. | |||
Plasminogen | == Indications == | ||
Plasminogen is indicated for use in patients with congenital plasminogen deficiency, which can lead to the development of [[ligneous conjunctivitis]], a condition characterized by the formation of wood-like pseudomembranes on the [[conjunctiva]]. | |||
== | == Administration == | ||
Plasminogen is administered via [[intravenous]] infusion. The dosage and frequency depend on the severity of the deficiency and the clinical response of the patient. | |||
== Side Effects == | |||
Common side effects of plasminogen therapy may include [[allergic reactions]], [[fever]], and [[headache]]. Serious side effects are rare but can include [[anaphylaxis]] and [[thrombosis]]. | |||
=== | == Contraindications == | ||
Plasminogen should not be used in patients with known hypersensitivity to the drug or any of its components. It is also contraindicated in patients with active [[bleeding disorders]]. | |||
== See Also == | == See Also == | ||
* [[Fibrinolysis]] | * [[Fibrinolysis]] | ||
* [[Thrombosis]] | |||
* [[Tissue plasminogen activator]] | * [[Tissue plasminogen activator]] | ||
== References == | == References == | ||
{{Reflist}} | |||
== External Links == | |||
* [https://www.wikimd.com/wiki/Plasminogen_(medication) Plasminogen on WikiMD] | |||
[[Category:Medications]] | |||
[[Category:Hematology]] | |||
[[Category:Enzymes]] | |||
[[Category:Blood and blood forming organs]] | |||
Latest revision as of 16:48, 29 December 2024
| Plasminogen (medication) | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Plasminogen is a medication used in the treatment of certain medical conditions related to fibrinolysis. It is a precursor to plasmin, an important enzyme that breaks down fibrin clots. This medication is primarily used in the management of hypoplasminogenemia, a rare condition characterized by low levels of plasminogen in the blood.
Mechanism of Action[edit]
Plasminogen is converted into its active form, plasmin, by tissue plasminogen activator (tPA) or urokinase. Plasmin then degrades fibrin, a key component of blood clots, into soluble fragments. This process is crucial for the maintenance of normal blood flow and prevention of thrombosis.
Indications[edit]
Plasminogen is indicated for use in patients with congenital plasminogen deficiency, which can lead to the development of ligneous conjunctivitis, a condition characterized by the formation of wood-like pseudomembranes on the conjunctiva.
Administration[edit]
Plasminogen is administered via intravenous infusion. The dosage and frequency depend on the severity of the deficiency and the clinical response of the patient.
Side Effects[edit]
Common side effects of plasminogen therapy may include allergic reactions, fever, and headache. Serious side effects are rare but can include anaphylaxis and thrombosis.
Contraindications[edit]
Plasminogen should not be used in patients with known hypersensitivity to the drug or any of its components. It is also contraindicated in patients with active bleeding disorders.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>